Search Results - Ye Peng

Ye Peng

Ye Peng as pictured in ''[[The Most Recent Biographies of Chinese Dignitaries Ye Peng (, sometimes also transliterated Ye Feng, 1897–1947) was a Chinese lieutenant general who fought for the Republic of China and later became a key figure in the Nanjing Nationalist Government of Wang Jingwei. Provided by Wikipedia
  • Showing 1 - 8 results of 8
Refine Results
  1. 1
    Cover Image

    Neuroinflammatory In Vitro Cell Culture Models and the Potential Applications for Neurological Disorders by Ye Peng, Ye Peng, Shifeng Chu, Yantao Yang, Zhao Zhang, Zongran Pang, Naihong Chen, Naihong Chen, Naihong Chen

    Published 2021
    Connect to this object online.
    Book

    Save to List
    Saved in:
  2. 2
    Cover Image

    Cost-Effectiveness Analysis of Hepatic Arterial Infusion Chemotherapy of Infusional Fluorouracil, Leucovorin, and Oxaliplatin Versus Transarterial Chemoembolization in Patients Wit... by Haixia Zhang, Xiaohui Zeng, Ye Peng, Chongqing Tan, Xiaomin Wan

    Published 2022
    Connect to this object online.
    Book

    Save to List
    Saved in:
  3. 3
    Cover Image

    Cost-Effectiveness of Pembrolizumab Plus Chemotherapy as First-Line Therapy for Advanced Oesophageal Cancer by Meiyu Wu, Meiyu Wu, Shuxia Qin, Shuxia Qin, Liting Wang, Liting Wang, Chongqing Tan, Chongqing Tan, Ye Peng, Ye Peng, Xiaohui Zeng, Xia Luo, Xia Luo, Lidan Yi, Lidan Yi, Xiaomin Wan, Xiaomin Wan

    Published 2022
    Connect to this object online.
    Book

    Save to List
    Saved in:
  4. 4
    Cover Image

    Economic Evaluation of Dapagliflozin in the Treatment of Patients With Heart Failure: A Systematic Review by Meiyu Wu, Meiyu Wu, Shuxia Qin, Shuxia Qin, Liting Wang, Liting Wang, Chongqing Tan, Chongqing Tan, Ye Peng, Ye Peng, Xiaohui Zeng, Xia Luo, Xia Luo, Lidan Yi, Lidan Yi, Xiaomin Wan, Xiaomin Wan

    Published 2022
    Connect to this object online.
    Book

    Save to List
    Saved in:
  5. 5
    Cover Image

    Benefit-to-harm ratio and cost-effectiveness of government-recommended gastric cancer screening in China: A modeling study by Shuxia Qin, Xuehong Wang, Sini Li, Sini Li, Chongqing Tan, Xiaohui Zeng, Meiyu Wu, Ye Peng, Liting Wang, Xiaomin Wan

    Published 2022
    Connect to this object online.
    Book

    Save to List
    Saved in:
  6. 6
    Cover Image

    Cost-Effectiveness Analysis of Nivolumab Plus Ipilimumab for Advanced Non-Small-Cell Lung Cancer by Xiaomin Wan, Xiaohui Zeng, Liubao Peng, Ye Peng, Qiao Liu, Lidan Yi, Xia Luo, Qijian Deng, Qijian Deng, Chongqing Tan

    Published 2021
    Connect to this object online.
    Book

    Save to List
    Saved in:
  7. 7
    Cover Image

    Sintilimab Plus Bevacizumab Biosimilar Versus Sorafenib as First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Cost-Effectiveness Analysis by Ye Peng, Xiaohui Zeng, Liubao Peng, Qiao Liu, Lidan Yi, Xia Luo, Sini Li, Liting Wang, Shuxia Qin, Xiaomin Wan, Chongqing Tan

    Published 2022
    Connect to this object online.
    Book

    Save to List
    Saved in:
  8. 8
    Cover Image

    Low-dose-rate induces more severe cognitive impairment than high-dose-rate in rats exposed to chronic low-dose γ-radiation by Tianbao Ma, Tianbao Ma, Kexian Li, Wenjuan Sang, Xingyu Liu, Qun Luo, Ye Peng, Mingxing Wang, Xiu Luo, Jingjing Fang, Haijun Wang, Tao Wang, Changjing Zuo, Changjing Zuo

    Published 2024
    Connect to this object online.
    Book

    Save to List
    Saved in:

Search Tools: